IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Propel Bio Management, LLC

Q2 2024 Holdings

Filed 2024-08-12 | 25 holdings | $154.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Applied Therapeutics Inc(APLT)COMM03828A101$30.7M6,567,85820.2%
Plains GP Holdings LP-Cl(PAGPEUR)COMM72651A207$25.8M1,372,36017.0%
Tscan Therapeutics Inc(TCRX)COMM89854M101$12.2M2,087,1398.1%
Madrigal Pharmaceuticals(MDGL)COMM558868105$12.1M43,0328.0%
Achieve Life Sciences Inc(ACHV)COMM004468500$11.5M2,453,0927.6%
Phathom Pharmaceuticals I(PHAT)COMM71722W107$9.0M869,9275.9%
Akero Therapeutics Inc(AKRO)COMM00973Y108$7.7M327,7525.1%
Avidity Biosciences Inc(RNA)COMM05370A108$7.3M178,5004.8%
Ardelyx Inc(ARDX)COMM039697107$6.9M924,5834.5%
Fulcrum Therapeutics Inc(FULC)COMM359616109$4.7M750,0003.1%
Athira Pharma IncCOMM04746L104$4.0M1,492,7922.6%
Telesat Corp(TSAT)COMM879512309$3.3M365,7812.2%
Verrica Pharmaceuticals ICOMM92511W108$3.1M424,9372.0%
Kura Oncology Inc(KURA)COMM50127T109$2.7M130,0001.8%
Abeona Therapeutics Inc(ABEO)COMM00289Y206$2.6M624,0221.7%
Eiger Biopharmaceuticals(72C)COMM28249U204$1.9M146,3811.2%
Syndax Pharmaceuticals in(SNDX)COMM87164F105$1.7M83,2591.1%
Kymera Therapeutics Inc(KYMR)COMM501575104$1.7M56,3591.1%
Kayne Anderson Energy INF(KYN)COMM486606106$1.5M147,0331.0%
Trevi Therapeutics Inc(TRVI)COMM89532M101$774.8K260,0000.5%
Fidelity INV Mmtrsy 1 680COMMX9USDFIDT$317.0K317,0140.2%
Cybin Inc(CYBNEUR)COMM23256X100$230.4K850,0000.2%
Maat Pharma SacaCOMM00BNRR5C1$9.8K1,3620.0%
Chinook Therapeutics(KDNY)COMM169CVR016$9.8K79,3570.0%